ASH 2022: Venetoclax with CLIA highly effective in younger patients with newly diagnosed AML and high-risk MDS
The latest results of a Phase II study evaluating the addition of venetoclax to the…
Browsing: mixed phenotype acute leukaemia
New insights into treating a rare leukaemia
A study at Children’s Hospital Los Angeles is shedding new light on the best therapeutic…